Literature DB >> 2613881

Formation of new quasi-crystalline ordered aggregates by gizzard myosin.

S S Margossian1, J R Sellers, S C Watkins, H S Slayter.   

Abstract

Turkey gizzard myosin was found to self-assemble into new polymorphic forms as detected by thin-section electron microscopy. In high ionic strength buffers (0.3 mM KCl, pH 6.0), aggregates of sidepolar filaments were produced. Electron microscopy of thin sections revealed individual filaments with a 13.5 nm axial repeat. Under a number of conditions, with varying ionic strength, pH, MgCl2 and ATP, the filaments assembled through the head region with the tail portion projecting out radially from the aggregate. The regions corresponding to heads and tails within the aggregates were established by immunoelectron microscopy using anti-S1 and anti-LMM antibodies coupled to gold. These filaments often interacted to produce bilayer sheets, which, when cut perpendicular to the plane of the sheet, appeared as ladders. A hitherto unreported structure was obtained at 0.2 M KCl (pH 8.0): myosin aggregated to generate a three-dimensional quasi-crystalline lattice with a 270 nm period. In these aggregates, myosin was arranged in an antiparallel fashion, stacked on one another, producing ribbon-like strips stabilized through non-covalent interactions between heads, thereby producing a crystalline lattice. Neither Mg2+ nor ATP were required for this form. Phosphorylation of the regulatory light chains or the cleavage of the heavy chains at a single site in the head region prevented myosin from assembling in the 3-D lattice form. Generally, unphosphorylated myosin produced periodic paracrystals at low ionic strength in the presence of 10 mM MgCl2, but as the ionic strength was increased the regular 3-D lattice became the predominant form. Some paracrystalline forms could be obtained at high ionic strength without magnesium with phosphorylated myosin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2613881     DOI: 10.1007/bf01771817

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  29 in total

1.  Structure and function of chicken gizzard myosin.

Authors:  H Suzuki; H Onishi; K Takahashi; S Watanabe
Journal:  J Biochem       Date:  1978-12       Impact factor: 3.387

2.  Assembly of myosin.

Authors:  R G Harrison; S Lowey; C Cohen
Journal:  J Mol Biol       Date:  1971-08-14       Impact factor: 5.469

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Preparation of myosin and its subfragments from rabbit skeletal muscle.

Authors:  S S Margossian; S Lowey
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

5.  Mode of filament assembly of myosins from muscle and nonmuscle cells.

Authors:  H Hinssen; J D'Haese; J V Small; A Sobieszek
Journal:  J Ultrastruct Res       Date:  1978-09

6.  Proteolytic susceptibility of both isolated and bound light chains from various myosins to myopathic hamster protease.

Authors:  S S Margossian; P D Chantler; J R Sellers; A Malhotra; W F Stafford; H S Slayter
Journal:  J Biol Chem       Date:  1984-11-10       Impact factor: 5.157

7.  Epiglycanin as a membrane glycoprotein. Isolation of plasma membrane from the TA3-Ha tumor cell.

Authors:  A Schmit; J F Condington; H S Slayter
Journal:  Carbohydr Res       Date:  1986-08-15       Impact factor: 2.104

8.  Assembly of smooth muscle myosin minifilaments: effects of phosphorylation and nucleotide binding.

Authors:  K M Trybus; S Lowey
Journal:  J Cell Biol       Date:  1987-12       Impact factor: 10.539

9.  ATP-linked monomer-polymer equilibrium of smooth muscle myosin: the free folded monomer traps ADP.Pi.

Authors:  R A Cross; K E Cross; A Sobieszek
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

10.  Assembly of smooth muscle myosin into side-polar filaments.

Authors:  R Craig; J Megerman
Journal:  J Cell Biol       Date:  1977-12       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.